Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments

被引:176
作者
Robinson, Paul
Griffiths, Peter J.
Watkins, Hugh
Redwood, Charles S. [1 ]
机构
[1] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[2] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX3 7BN, England
关键词
cardiomyopathy; calcium; troponin; signaling;
D O I
10.1161/CIRCRESAHA.107.156380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dilated cardiomyopathy and hypertrophic cardiomyopathy (HCM) can be caused by mutations in thin filament regulatory proteins of the contractile apparatus. In vitro functional assays show that, in general, the presence of dilated cardiomyopathy mutations decreases the Ca(2+) sensitivity of contractility, whereas HCM mutations increase it. To assess whether this functional phenomenon was a direct result of altered Ca(2+) affinity or was caused by altered troponin - tropomyosin switching, we assessed Ca(2+) -binding of the regulatory site of cardiac troponin C in wild-type or mutant troponin complex and thin filaments using a fluorescent probe (2-[4'-{iodoacetamido}aniline]-naphthalene-6-sulfonate) attached to Cys35 of cardiac troponin C. The Ca(2+)-binding affinity (pCa(50) = 6.57 +/- 0.03) of reconstituted troponin complex was unaffected by all of the HCM and dilated cardiomyopathy troponin mutants tested, with the exception of the troponin I Arg145Gly HCM mutation, which caused an increase ( Delta pCa(50) = +0.31 +/- 0.05). However, when incorporated into regulated thin filaments, all but 1 of the 10 troponin and - tropomyosin mutants altered Ca(2+)-binding affinity. Both HCM mutations increased Ca(2+) affinity (Delta pCa(50) = +0.41 +/- 0.02 and + 0.51 +/- 0.01), whereas the dilated cardiomyopathy mutations decreased affinity (Delta pCa(50) = + 0.12 +/- 0.04 to - 0.54 +/- 0.04), which correlates with our previous functional in vitro assays. The exception was the troponin T Asp270Asn mutant, which caused a significant decrease in cooperativity. Because troponin is the major Ca(2+) buffer in the cardiomyocyte sarcoplasm, we suggest that Ca(2+) affinity changes caused by cardiomyopathy mutant proteins may directly affect the Ca(2+) transient and hence Ca(2+)-sensitive disease state remodeling pathways in vivo. This represents a novel mechanism for this class of mutation.
引用
收藏
页码:1266 / 1273
页数:8
相关论文
共 41 条
  • [31] ROSENFELD SS, 1985, J BIOL CHEM, V260, P252
  • [32] Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
    Schmitt, JP
    Kamisago, M
    Asahi, M
    Li, GH
    Ahmad, F
    Mende, U
    Kranias, EG
    MacLennan, DH
    Seidman, JG
    Seidman, CE
    [J]. SCIENCE, 2003, 299 (5611) : 1410 - 1413
  • [33] The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms
    Seidman, JG
    Seidman, C
    [J]. CELL, 2001, 104 (04) : 557 - 567
  • [34] Ca2+ buffering in the heart:: Ca2+ binding to and activation of cardiac myofibrils
    Smith, GA
    Dixon, HBF
    Kirschenlohr, HL
    Grace, AA
    Metcalfe, JC
    Vandenberg, JI
    [J]. BIOCHEMICAL JOURNAL, 2000, 346 : 393 - 402
  • [35] Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy
    Szczesna, D
    Zhang, R
    Zhao, JJ
    Jones, M
    Guzman, G
    Potter, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) : 624 - 630
  • [36] Structure of the core domain of human cardiac troponin in the Ca2+-saturated form
    Takeda, S
    Yamashita, A
    Maeda, K
    Maéda, Y
    [J]. NATURE, 2003, 424 (6944) : 35 - 41
  • [37] ALPHA-TROPOMYOSIN AND CARDIAC TROPONIN-T MUTATIONS CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A DISEASE OF THE SARCOMERE
    THIERFELDER, L
    WATKINS, H
    MACRAE, C
    LAMAS, R
    MCKENNA, W
    VOSBERG, HP
    SEIDMAN, JG
    SEIDMAN, CE
    [J]. CELL, 1994, 77 (05) : 701 - 712
  • [38] Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy
    Tobacman, LS
    Lin, D
    Butters, C
    Landis, C
    Back, N
    Pavlov, D
    Homsher, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) : 28363 - 28370
  • [39] Thin filament-mediated regulation of cardiac contraction
    Tobacman, LS
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1996, 58 : 447 - 481
  • [40] VANEYK JE, 1988, J BIOL CHEM, V263, P1726